SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 91 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 6.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $6,000 | +100.0% | 6,430 | +94.8% | 0.00% | – |
| Q1 2022 | $3,000 | -62.5% | 3,300 | +35.2% | 0.00% | – |
| Q4 2021 | $8,000 | +700.0% | 2,440 | +454.5% | 0.00% | – |
| Q3 2021 | $1,000 | -66.7% | 440 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 440 | +10.0% | 0.00% | – |
| Q1 2021 | $3,000 | +200.0% | 400 | +300.0% | 0.00% | – |
| Q4 2020 | $1,000 | -83.3% | 100 | -84.6% | 0.00% | – |
| Q3 2020 | $6,000 | -14.3% | 650 | 0.0% | 0.00% | – |
| Q2 2020 | $7,000 | +75.0% | 650 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | – | 650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |